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Abstract 
Background: Progress in reducing the malaria disease burden through the substantial scale up of insecticide‑based 
vector control in recent years could be reversed by the widespread emergence of insecticide resistance. The impact 
of insecticide resistance on the protective effectiveness of insecticide‑treated nets (ITN) and indoor residual spraying 
(IRS) is not known. A multi‑country study was undertaken in Sudan, Kenya, India, Cameroon and Benin to quantify the 
potential loss of epidemiological effectiveness of ITNs and IRS due to decreased susceptibility of malaria vectors to 
insecticides. The design of the study is described in this paper.
Methods: Malaria disease incidence rates by active case detection in cohorts of children, and indicators of insecti‑
cide resistance in local vectors were monitored in each of approximately 300 separate locations (clusters) with high 
coverage of malaria vector control over multiple malaria seasons. Phenotypic and genotypic resistance was assessed 
annually. In two countries, Sudan and India, clusters were randomly assigned to receive universal coverage of ITNs 
only, or universal coverage of ITNs combined with high coverage of IRS. Association between malaria incidence and 
insecticide resistance, and protective effectiveness of vector control methods and insecticide resistance were esti‑
mated, respectively.
Results: Cohorts have been set up in all five countries, and phenotypic resistance data have been collected in all 
clusters. In Sudan, Kenya, Cameroon and Benin data collection is due to be completed in 2015. In India data collection 
will be completed in 2016.
Discussion: The paper discusses challenges faced in the design and execution of the study, the analysis plan, the 
strengths and weaknesses, and the possible alternatives to the chosen study design.
© 2015 Kleinschmidt et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
*Correspondence:  Immo.Kleinschmidt@lshtm.ac.uk 
1 MRC Tropical Epidemiology Group, Department of Infectious Disease 
Epidemiology, London School of Hygiene and Tropical Medicine, Keppel 
Street, London WC1E 7HT, UK
Full list of author information is available at the end of the article
Page 2 of 13Kleinschmidt et al. Malar J  (2015) 14:282 
Background
Reductions in malaria disease burden, as documented in 
recent World Malaria Reports [1, 2], have coincided with 
the massive scale-up of malaria prevention measures, of 
which vector control was the predominant component, 
particularly in sub-Saharan Africa. The core malaria vec-
tor control interventions are insecticide-treated nets 
(ITNs) and indoor residual spraying (IRS), both of which 
deploy insecticides to kill malaria-transmitting mosqui-
toes. In populations at risk of malaria in sub-Saharan 
Africa, the proportion of households owning at least 
one ITN increased from 3% in 2000 to 67% in 2013, with 
the proportion of the population sleeping under a net 
increasing from 2 to 44% over the same period. In 2014, 
the number of ITNs delivered in the region was projected 
to reach 214 million. The proportion of the population 
at risk of malaria in the WHO African region who were 
protected by IRS, increased from 5% in 2005 to 11% in 
2011, but fell to 7% in 2013, possibly in response to hav-
ing to spray more expensive insecticides required for the 
management of insecticide resistance [3]. Globally 3.5% 
of populations at risk of malaria were protected by IRS 
in 2013.
Whilst these substantial efforts have had a major 
impact on malaria disease burden, the global burden 
of malaria is still unacceptably high. Worldwide there 
were an estimated 584,000 malaria deaths and 198 mil-
lion malaria cases in 2013. However, malaria mortality 
rates fell by 47% and malaria cases per 1,000 persons at 
risk declined by 30% between 2000 and 2013. In Africa 
malaria infection prevalence in children aged 2–10 years 
reduced continent-wide from 26% in 2000 to 14% in 2013, 
whilst prevalence in countries with stable transmission 
fell from 35 to 18% over the same period [2]. Individual 
studies suggest that reductions in malaria incidence and 
infection prevalence have often occurred in the wake of 
the introduction or scale-up of vector control interven-
tions [4–6].
These successes are now being threatened by the wide-
spread emergence of insecticide resistance, especially 
in sub-Saharan Africa and India [3]. Resistance to pyre-
throids, which is currently the only insecticide class used 
in ITNs, is now ubiquitous in major vectors of malaria 
on the African continent. Resistance to insecticides that 
belong to the other three chemical classes used for IRS is 
emerging in many regions where insecticides are used for 
vector control [7–9].
The Global Plan for Insecticide Resistance Management 
in Malaria Vectors [3] sets out the strategies that countries 
should employ to monitor and manage insecticide resist-
ance. Whilst there is extensive evidence of resistance in 
Anopheles mosquitoes, there is little evidence of control 
programme failure associated directly with insecticide 
resistance largely because of many confounding factors. In 
KwaZulu-Natal, South Africa, a sharp increase in malaria 
cases from <5,000 to approximately 50,000 cases per year 
in the 1990s coincided with a switch in IRS insecticide from 
DDT to the pyrethroid deltamethrin [10]. Insecticide sus-
ceptibility tests showed that there was resistance to pyre-
throids in Anopheles funestus, a vector that was previously 
driven to near extinction in KwaZulu-Natal [11]. A change 
in policy that re-introduced IRS with DDT in 2000 was fol-
lowed by a rapid decline in cases which was maintained in 
subsequent years. This example is a powerful reminder of 
the damage that can be caused by failing insecticides, par-
ticularly if insecticide policy is not based on appropriate 
susceptibility testing. Although this example constitutes 
the strongest indication of malaria operational programme 
failure resulting from insecticide resistance, it is somewhat 
undermined by the simultaneous switch from sulfadoxine/
pyrimethamine (SP) to artemether/lumefantrine as a first-
line drug in 2001, due to documented drug resistance to SP 
in Plasmodium falciparum [12].
Another cited example of apparent malaria control fail-
ure due to insecticide resistance is Bioko Island, Equa-
torial Guinea, where IRS with deltamethrin was used 
against Anopheles gambiae s.s. which harboured a kdr 
mutation often associated with pyrethroid resistance 
[13]. However, subsequent detailed analyses of locality 
by locality disaggregation of available data cast doubt on 
the initial interpretation [5, 14]. A recent review [15] con-
cluded that regardless of pyrethroid resistance, ITNs are 
superior to untreated nets in terms of mosquito mortality 
in semi-field hut trials and laboratory cone bio-assays.
These examples do not suggest that insecticide resist-
ance does not pose a substantial and real threat to malaria 
vector control, but rather they demonstrate how difficult 
it is to assess the evidence of epidemiological impact of 
insecticide resistance when relying on historical data. To 
address this, a multi-country prospective study to assess 
the impact of insecticide resistance on the effectiveness 
of long lasting insecticidal nets (LLINs) and IRS was ini-
tiated in five countries, namely Benin, Cameroon, India, 
Kenya and Sudan, co-ordinated by the World Health 
Organization (WHO) and with primary funding from the 
Bill and Melinda Gates Foundation. This paper describes 
the design that was adopted for conducting this study.
The principal objectives of the study were:
1. To determine the impact of insecticide resistance 
in malaria vectors on the protective effectiveness of 
ITNs and IRS and hence on malaria disease burden;
2. To assess trends in the insecticide resistance status 
and underlying mechanisms in the main malaria vec-
tor species from the study areas in response to differ-
ent interventions.
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Methods
The objective of this study required an observational 
design since insecticide resistance (IR), the exposure of 
interest, could not be randomly allocated. To gain sta-
tistical power, it was necessary to conduct as many inde-
pendent observations relating IR to a measure of vector 
control effectiveness as possible. Figure 1 summarizes the 
overall study design.
IR was characterized in the mosquito populations to 
which human populations, in whom disease burden was 
estimated, were exposed. Therefore IR assessments were 
made in mosquitoes caught in the neighbourhood of the 
human cohorts in which cases arose. As there was no way 
of knowing whether malaria cases were a result of bites 
from resistant or susceptible mosquitoes, information on 
resistance status of mosquitoes in the area was used as a 
proxy of individual exposure to infective IR mosquitoes. 
Any association between incident cases and the exposure 
was investigated at the level of a cluster (area). In this 
respect the study has an ecological study design.
Figure 1 Schematic summary of the study design.
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In the study areas in the five countries, the impact of 
IR on epidemiological malaria outcomes in relation to the 
presence of insecticide-based interventions was assessed 
using one or both of the two approaches described below. 
The study was designed on the basis of use of LLINs at 
high coverage rates at all study sites in accordance with 
WHO policy [16].
Approach 1
The following explanation of the study design is in terms 
of ITNs as a vector control intervention since ITNs were 
used in all study sites. A similar elaboration is implied for 
IRS.
The study outcome was vector control intervention 
effectiveness in localities with vectors with IR in compar-
ison to those with susceptible vectors. Consider a group 
of villages randomly assigned to receive ITNs (the inter-
vention group) and a similar group of villages assigned to 
not receive the intervention (the control group). Malaria 
incidence in the intervention group is denoted as IITN 
and malaria incidence in the control group is denoted 
as INoITN. A measure of intervention effectiveness is the 
incidence rate ratio IITN/INoITN: the smaller the ratio, 
the more effective the intervention, other factors being 
similar. Effectiveness of ITNs could then be measured in 
areas with susceptible vectors (s areas) and in areas with 
resistant vectors (r areas) as illustrated in Figure 2.
Loss of effectiveness can be quantified by comparing 
the effectiveness of ITNs in areas with resistant vectors 
to the effectiveness of ITNs in areas with susceptible vec-
tors by taking the ratio of rate ratios (RR), (IITN,r/INoITN,r)/
(IITN,s/INoITN,s) where the subscripts r and s refer to resist-
ant and susceptible areas, respectively. This ratio ranges 
from 0 to 1, where the smaller the ratio the larger the loss 
of effectiveness in areas of resistance (with a value of 1 
indicating no loss of effectiveness).
Ethically, a trial with a neutral control group that was 
not to receive a prevention measure (i.e., vector con-
trol) was unacceptable since it is known that these 
interventions are effective. This was also not a viable 
approach given that almost all communities in malaria-
endemic countries now have a certain level of ITN cov-
erage anyway. The two quantities INoITN,r and INoITN,s 
therefore cannot be measured.
However, it is reasonable to assume that IR will not 
cause an increase in malaria incidence in places where 
there is no insecticide-based vector control, if all other 
transmission factors are comparable. If susceptible vec-
tors are more competent than resistant vectors, then 
INoITN,r ≤ INoITN,s. The two effects of resistance and vector 
competence in resistant vectors cannot be disentangled 
in this study; from the perspective of malaria vector con-
trol the combined impact of resistance and potentially 
reduced vector competence is of key importance; it is this 
combined impact that this study is designed to estimate.
Impact of resistance on relative risk due to the 
intervention
if INoITN,r = INoITN,s.
The outcome measure for estimating loss of effec-
tiveness would therefore be the ratio IITN,r/IITN,s where 
IITN,r and IITN,s refer to mean incidence in communities 
with ITNs where vectors are resistant and similar com-
munities where vectors are susceptible, respectively. It 
is possible that areas with resistance and those without 
resistance may differ not just in their resistance status, 
but by other factors that are associated with malaria inci-
dence. This would result in the two quantities that can-
not be measured INoITN,r and INoITN,s being unequal. As 
far as is possible estimates of the impact of IR should be 
adjusted for such confounders if they are measurable.
IR was measured annually as it was likely to change 
during the course of the study. It was therefore treated as 
a time-dependent exposure in the analysis. The hypoth-
esis of higher average malaria incidence in localities 
of lower susceptibility to insecticide is illustrated with 
=
RRr
RRs
=
IITN ,r/INoITN,r
IITN ,s/INoITN,s
=
IITN ,r
IITN ,s
Figure 2 Schematic of measurement of ITN effectiveness in areas with susceptible and areas with resistant vectors.
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hypothetical data in the scatterplot of cluster-specific 
malaria incidence versus cluster-specific mosquito mor-
tality in Figure 3.
Even though no randomization of the exposure (IR) 
was possible, a cluster design was used to generate as 
large a number of observations of malaria outcomes and 
IR as feasible, and thereby gain statistical power. Each 
cluster acted as an entomological and as an epidemiolog-
ical sampling point. Clusters were chosen to be villages 
or groups of hamlets with at least 500 houses that were 
at least 2  km apart but with greater separation where 
possible [17]. Households for the assessment of epide-
miological outcomes were selected on the basis of close 
proximity to the habitats at which mosquitoes were col-
lected for measurement of IR. In Sudan and India, clus-
ters could be randomly allocated to receive either IRS in 
combination with ITNs, or ITNs alone. These two coun-
try studies had the advantage of allowing the assessment 
of the differential impact of resistance on the combina-
tion of interventions relative to a single intervention, and 
the evaluation of differences in temporal trends in resist-
ance due to differences in selection pressure exerted by 
the combination relative to the single intervention.
Approach 2
ITN effectiveness can also be assessed by comparing 
infection prevalence between ITN users and non-users 
in cross-sectional surveys. This is in principle a case con-
trol study design comparing ITN usage between infected 
(case) and non-infected (control) individuals. In a cross-
sectional survey the protection offered by ITNs can be 
estimated in each cluster from the prevalence odds ratio
ORITN versus NoITN
= [PITN/(1− PITN)]/[PNoITN/(1− PNoITN)]
where PITN is the infection prevalence in ITN users and 
PNoITN is the infection prevalence among non users of 
nets. If the ITNs are effective, one would expect ORITN 
versus NoITN <1; if they are less effective or ineffective one 
would expect this odds ratio to be close to 1. Estimating 
infection prevalence in clusters with resistant and sus-
ceptible vectors would yield a measure of the impact of 
IR by computing the ratio of odds ratios
for all clusters combined. Alternatively, retaining resist-
ance as a continuous variable, the loss of effectiveness 
of ITNs could be assessed by estimating the coefficient 
of the linear regression of ORITN versus NoITN on mosquito 
susceptibility, i.e., computing the slope of the plot of 
ORITN versus NoITN versus mortality.
Primary outcomes
In all five countries, malaria incidence was measured by 
active case detection in cohorts of children recruited in 
each study cluster. A total of 44,720 children were fol-
lowed up. Prevalence of infection was measured through 
cross-sectional surveys, also in each cluster, in Sudan, 
Kenya, Cameroon and Benin. Active infection detec-
tion was carried out in the three high transmission study 
areas (Benin, Cameroon and Kenya), again in cluster spe-
cific cohorts. Although passive case detection data were 
available in Benin and India, the reliability of these data 
could not be guaranteed and this indicator was therefore 
not intended for primary analysis. Each of the outcome 
indicators were measured in each study cluster. Table  1 
shows which outcomes were measured in each of the five 
countries.
The four epidemiological outcome indicators are 
described below.
Clinical malaria incidence from active case detection cohorts
Cohorts of children were recruited in each study cluster 
(see Table 2 for size of cohorts in each country) in close 
proximity to the site from which mosquitoes were col-
lected to test for susceptibility to insecticide. Children 
were enrolled into the cohort if the parent or caregiver 
consented after receiving an explanation of the study 
procedures. Cohort members were visited weekly or fort-
nightly by a community health worker during the malaria 
season. If a child was febrile, or had a recent history of 
fever, they were tested for malaria infection by RDT. For 
the purpose of estimating malaria incidence, a malaria 
case diagnosis was defined as having a positive blood test 
and having fever or having had recent fever. The com-
munity health worker would also ask whether the child 
had visited a health facility since they were last seen and 
investigate whether a blood test was done that confirmed 
ORITN versus NoITN, r/ORITN versus NoITN, s
Figure 3 Hypothetical data of cluster specific malaria incidence in 
relation to hypothetical cluster specific mosquito mortality from WHO 
bioassay susceptibility tests.
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the diagnosis of malaria. Children who tested positive 
were treated according to national treatment guidelines, 
or were referred to a local health facility for treatment. 
For a period of 2 weeks following treatment, children in 
cohorts were regarded as being under prophylaxis and 
hence not at risk. Use of ITNs the night before the visit 
was assessed by interviewing the household head or car-
egiver at each visit. The condition of nets was observed 
and recorded periodically. Active case detection cohorts 
were followed continuously, but children were released 
from cohorts when they had reached the upper age limit, 
upon which they were replaced by a younger child.
Infection incidence in cohorts with repeated testing 
regardless of symptoms
In the three high-transmission countries, cohorts of 
children under 5  years of age were recruited in each 
cluster and visited fortnightly (see Table 2). At recruit-
ment and following written consent, all children were 
given a treatment dose of the first-line anti-malarial 
drug for the particular country [either artemether/
lumefantrine (AL) or artesunate/amodiaquine (ASAQ)], 
for clearance of any parasites. At the first visit following 
treatment (visit 1), a blood-slide was taken for micro-
scopic examination to verify that children had been suc-
cessfully cleared of parasites; those positive were treated 
or referred for treatment, and released from the cohort. 
The period between recruitment and visit 1 was not 
included as time at risk for the purpose of incidence cal-
culations since children were assumed to be protected 
by the prophylactic effect of treatment. At subsequent 
visits, children were tested by RDT. In Cameroon and 
initially in Kenya only those having symptoms (febrile) 
were tested every second fortnightly visit whilst all chil-
dren were tested at least monthly. Details of visits to 
health facilities which took place between scheduled 
health worker visits, were recorded. Once a child tested 
positive they were treated and left the cohort. A new 
active infection detection (AID) cohort was recruited 
each year at the start of the malaria season. Whether 
the child slept under an ITN the night before the visit 
was determined at each visit from the caregiver. The 
physical condition of nets was observed and recorded at 
the time of recruitment.
Prevalence of infection with Plasmodium parasites
Cross-sectional malaria indicator surveys were per-
formed in each study cluster to determine prevalence of 
infection of malarial parasites in children. The frequency 
of surveys and the age range of children eligible for inclu-
sion varied between countries. Generally, blood tests 
were performed by RDT; in Benin microscopic exami-
nation of blood films was carried out. Survey question-
naires were adapted from the standard RBM Monitoring 
and Evaluation Reference Group malaria indicator survey 
and included questions on ITN use [19]. In Sudan, dried 
blood spots on filter paper were collected for PCR analy-
sis on a subsample of specimens. For molecular analysis, 
P. falciparum, was detected using real-time PCR assays 
from blood spots [20].
Clinical malaria case incidence from passive case detection
Incidence of malaria could be determined by passive case 
detection if a reliable system for reporting outpatient 
cases was in place, if a policy of testing all children under 
five presenting with a fever for malarial parasites was 
adhered to, if no stock-outs of slides or rapid diagnostic 
tests (RDTs) occurred and if diagnosis of malaria was 
only made if the patient tested positive by RDT or micro-
scopic blood-slide examination. In addition, the place of 
residence of reported cases had to be accurate enough to 
determine which study cluster the patient resided in. Pas-
sive case detection data were collected in Benin and India 
only, where these conditions were partially met. Passive 
case detection data were not used as a primary outcome 
indicator since their quality could not be guaranteed. 
Passive case detection served to supplement the more 
rigorously derived indicators.
Table 1 Epidemiological outcomes, by country
a Passive case detection will only be used as supplementary data.
Epidemiological 
outcome indicator
Clinical malaria incidence 
(fever plus infection)
Infection incidence Infection prevalence Malaria case incidence 
by passive case detectiona
Method Active case detection by test‑
ing cohort children who are 
febrile or report recent fever
Active infection detection  
by testing cohort children 
at 2 weeks intervals
Malaria indicator surveys testing a 
randomly selected cross‑section of 
children in study clusters
Passive case detection using 
clinic registers based on 
confirmed cases
Benin X X X X
Cameroon X X X
India X X
Kenya X X X
Sudan X X
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Exposure variables
The primary exposure variable, measured annually in 
each study cluster, was phenotypic susceptibility status 
to pyrethroids of the predominant local vector/s, meas-
ured as per cent mortality according to WHO adult sus-
ceptibility tests. In the majority of cases these adults were 
reared in the insectary from larvae collected in breeding 
sites within each study cluster. In certain cases (e.g. India) 
where larval sites were not detected, resting females were 
used, in line with WHO recommendations [21]. Female 
Anopheles mosquitoes were exposed to insecticides using 
WHO impregnated papers for 60  min at standard con-
centrations [21]. The mosquitoes were then maintained, 
where possible, at a temperature of 25 ± 2°C and humid-
ity of 80 ± 5%; mortality was measured at 24 h post-expo-
sure. Inadequate temperature and humidity control can 
result in excess mortality, illustrated in Figure  4. There 
is increasing evidence that WHO resistance prevalence 
assays may be an insensitive means of measuring changes 
in resistance, particularly when the level/intensity of 
resistance is high [22] and there are a number of novel 
approaches including modified CDC bottle bioassays 
and time/dose response assays that may be more sensi-
tive [23–25]. However, the power of this study was reliant 
upon obtaining a quantitative estimate of resistance for 
each study cluster and we took the pragmatic decision to 
maximize the number of clusters for which we obtained 
phenotypes at the expense of arguably more sensitive, but 
more laborious, intensity assays.
In areas in which the insecticide in most ITNs was del-
tamethrin (for example PermaNet® 2.0), susceptibility 
tests were conducted with deltamethrin. In areas where 
ITNs were in use in which permethrin was the active 
ingredient (for example, Olyset® net), susceptibility tests 
were carried out using this insecticide.
Allelic frequency of the Vgsc-L104F (formerly kdr-west) 
and Vgsc-L1014S (formerly kdr-east) mutation in Anoph-
eles arabiensis and/or An. gambiae s.s. was determined in 
samples of locally caught mosquitoes to provide a second 
measure of IR [26, 27]. The extent to which these muta-
tions are associated with phenotypic resistance is vari-
able and possibly location dependent [28, 29]. Resistance, 
whether phenotypic or genotypic, was observed as a con-
tinuous measure on a percentage scale.
Sample size considerations
For each country, a power calculation was performed to 
estimate a minimum difference in incidence or preva-
lence that could be detected between high and low resist-
ance clusters, based on the total number of clusters that 
Figure 4 The relationship between insecticide mortality and relative humidity in isofemale collections of Anopheles gambiae from Tororo, 
Uganda exposed to 0.75% permethrin for a population specific LT50 (the exposure time required to kill 50% of the population after a 24 h holding 
period). The line  in bold is a logistic regression of Mortality on relative humidity at time of exposure. (Mortality ~7.30 −0.12 RH; likelihood ratio test 
p < 0.0001; pseudo R2 = 0.163) (Muller et al. unpublished).
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could be formed with reasonable separation distance 
between clusters, and in which separate assessments of 
IR could be made. For the purpose of sample size cal-
culations it was assumed that there would be an equal 
number of low and high resistance clusters, i.e., that the 
clusters would be dichotomized based on median mos-
quito mortality. The total numbers of clusters for each 
country were as follows: Sudan (140), Kenya (50), Came-
roon (38), Benin (32), India (80). Details for each country 
are given in Table 2.
Data management
Data capture and management systems were set up in 
each country by information technology specialists. The 
structure of databases was standardized across coun-
tries. In case detection cohorts, follow-up was censored 
(excluded) if visits were missed, but children “re-entered” 
follow-up if they were observed at subsequent visits. 
Missing resistance data for a cluster meant that the clus-
ter could not be included in analysis for the particular 
year.
Ethics approval
In each country ethics approval for the study was 
obtained from the relevant national research ethics com-
mittee. Participation in the study was voluntary and 
based on written informed consent by the participant, or 
the caregiver in the case of children.
Country implementation
Malaria endemicity and baseline IR for the study settings 
are shown in Table  3. Key implementation details are 
shown in Table 2.
In Sudan and India clusters were randomized to receive 
either universal coverage with ITNs alone or IRS plus 
universal coverage of ITNs in combination. This allowed 
an additional evaluation to be conducted, the comparison 
of the combined use of IRS and ITNs with ITNs alone, in 
varying resistance settings. In Sudan, this randomization 
was restricted in such a way that the baseline frequency 
of genotypic IR in local vector populations was approxi-
mately equal in the two study arms, based on molecular 
analysis of local mosquitoes caught in each cluster at 
baseline [31]. In India, randomization was carried out 
separately in strata defined by the median of standard 
bioassay mortality of Anopheles culicifacies to bendio-
carb, carried out during baseline entomological surveys 
in each study cluster.
Analysis plan
All variables (outcome, exposure and confounders) were 
measured in each study cluster at different time points 
and analysis took account of the time dependent nature 
of the measurements. Although separate analyses are 
planned for each country, the statistical methodology 
described below is consistent across all countries.
For infection incidence (infection detection cohorts) 
and case incidence (case detection cohorts), incidence 
was estimated as the number of incident cases per child 
year of follow-up. Incidence RRs (or hazard ratios where 
appropriate) were calculated per 1% change in cluster 
specific vector susceptibility (mosquito mortality) or as 
incidence RRs in high resistance clusters, relative to low 
resistance clusters. Multiple variable Poisson or Cox 
regression was used to adjust estimated effects for meas-
ured potential confounders where appropriate. For cross-
sectional prevalence of infection data, logistic regression 
was used to estimate odds ratios, again per % change in 
cluster specific mosquito mortality or comparing preva-
lence in high versus low resistance clusters. All estimates 
of epidemiological outcomes used statistical methods 
that took account of the variation between clusters by 
either using random effects models, or the first-order 
Taylor-series linearization method as a robust variance 
estimator to calculate appropriate standard errors [32, 
33].
When resistance was analysed as a dichotomous vari-
able (‘high’ versus ‘low’ resistance), the median pheno-
typic and/or genotypic resistance value for all clusters 
was used as the cut-point, with each cluster classified 
as low or high resistance depending on which side of 
the cut-point it fell. Fixed definitions such as the WHO 
definition of susceptibility [3] of a minimum threshold of 
98% mortality in bioassay tests were not used, since there 
were generally too few or no clusters with susceptibility 
according to this definition. Moreover, such predefined 
thresholds do not necessarily reflect operational failure. 
Whether the relationship between case incidence and 
resistance was linear could not be pre-defined; therefore 
analyses using resistance as categorical and continuous 
variables were carried out.
In countries where clusters were randomized to LLINs 
alone versus LLINs plus IRS (Sudan and India), the effect 
of the combination compared to one method alone was 
assessed; the effect of resistance on the effect of the com-
bination was estimated as an effect modifier (interaction) 
in a multiple variable model. Table  4 is an illustration, 
using hypothetical data, of the way the results would be 
presented for clusters that were randomized to a single 
intervention (LLINs alone) versus combined interven-
tions (LLIN plus IRS), illustrating how loss of effective-
ness of the second intervention can be expressed as a 
ratio.
For Approach 2, effectiveness of LLINs was calculated 
as an odds ratio for infection prevalence between net 
users and non-users, in high and low resistance clusters, 
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respectively. Effectiveness odds ratios were compared 
through an interaction term in the model as a ratio of the 
two odds ratios. A similar analysis was carried out using 
incidence rate ratios for comparing incidence rates in 
users and non-users of ITNs.
Table 5 illustrates with hypothetical data how the esti-
mated of loss of effectiveness of nets due to resistance 
was estimated as an interaction, expressed as a ratio of 
odds ratios (>1 showing loss of effectiveness).
Discussion
Previous research on IR has generally been restricted to 
entomological outcomes. As a consequence there is little 
guidance on what the magnitude of its effect on malaria 
incidence is likely to be. Quantifying the health impact of 
IR is challenging, as no random allocation of the expo-
sure is possible. A possible alternative design would have 
been to randomly allocate treated and untreated nets 
to populations in areas of known IR to see whether the 
treated nets still conferred additional protection com-
pared to untreated nets. This would be based on the 
assumption that ITNs in the presence of resistance are, 
at worst, equivalent to untreated nets. A recent meta-
analysis of entomological studies on pyrethroid resist-
ance [15] concluded that ITNs are more effective against 
malaria than untreated nets, regardless of resistance. It 
would therefore be unethical to randomize individuals 
to receive either insecticide-treated vector control tools 
(ITNs) or untreated nets.
It is not known whether resistant mosquitoes are 
as competent as susceptible mosquitoes as vectors of 
malaria. If resistant mosquitoes are less efficient vec-
tors, as seen in a study of filariasis transmission [34], 
this effect could partially offset any loss of effectiveness 
of vector control due to IR. This study will only be able 
to measure the overall impact of IR in malaria vectors 
on vector control, without disentangling the separate 
effects of increased survival and possible loss of vector 
competence.
The results of an observational study may be sub-
ject to confounding. A way of guarding against this is 
through adjustment in the analysis for known confound-
ers although this does not provide a guarantee against 
unknown and unobserved confounders. Nevertheless, 
well-designed, non-randomized, observational, epide-
miological studies using long-term follow-up of cohorts 
have convincingly shown the effects of exposures that 
are harmful to human health, e.g., smoking [35], as well 
as exposures that are beneficial, e.g., physical exercise 
[36]. When such studies are ‘ecological’ studies because 
they rely on associations at community rather than indi-
vidual level, an additional layer of complexity is involved. 
The association between the outcome (e.g., malaria inci-
dence/prevalence) and an exposure (e.g. IR) at area level 
is sometimes referred to as ecological inference [37] 
and can be subject to hidden confounding unless the 
association is also true at individual level. In this case 
there was no means of verifying an association between 
Table 4 Tabulation of hypothetical data on incidence by active case detection in high and low resistance clusters, show-
ing loss of effectiveness of second intervention (IRS)
Insecticide  
resistance
Vector  
control
Incidence (cases per 
1,000 person years)
Rate ratio (LLIN + IRS  
versus LLIN)
Change in effectiveness ratio 
(high versus low resistance)
Low LLIN 100 1
LLIN + IRS 40 0.4 1
High LLIN 100 1
LLIN + IRS 80 0.8 2.0 [95% CI 1.1–5.0; p = 0.04]
Table 5 Hypothetical  illustration of  infection prevalence by  ITN use and  by resistance stratum demonstrating loss 
of effectiveness expressed as an odds ratio
Deltameth. resistance (2012) 
of clusters (no. of clusters)
ITN-use Infection prevalence,  
% (N)
ITN effectiveness Effect modification of resistance 
on effectiveness
Odds ratio ITN-use versus  
no net use
Change in effectiveness ratio, 
(high versus low resistance)
Low resistance (mortality ≥80%) No 49 1
Yes 27 0.4 1
High resistance (mortality <80%) No 37 1
Yes 30 0.7 1.75 [1.1–5.0]
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individual incident malaria cases and individual resistant 
mosquitoes.
Further challenges were the collection of malaria inci-
dence data in countries where reporting systems are 
weak, and difficulties collecting sufficient mosquito lar-
vae from each cluster for susceptibility testing. It was 
necessary to set up active case detection cohorts for the 
measurement of incidence, which is logistically challeng-
ing and requires intense supervision. Measuring IR in 
many locations is also challenging and requires standard-
ization of procedures and testing conditions such as tem-
perature and humidity. There are more sensitive methods 
of resistance determination such as generation of popula-
tion specific concentration or lethal exposure time curves 
[24, 38]. However these better metrics of the intensity of 
IR require multiple exposures per cluster which was not 
possible in logistically constrained study settings. The 
WHO susceptibility test measuring mosquito mortality 
within 24 h after 60 min of exposure to a standard con-
centration of insecticide on impregnated papers is com-
monly used and was considered operationally the most 
feasible.
The second approach described above, in which loss 
of effectiveness is measured as the ratio of odds ratios 
(interaction) in users and non-users of nets in high and 
low resistance clusters, respectively, has the advantage 
that the non-ITN users serve as a reference group. The 
drawback is that ITN use was not randomly allocated 
to individuals and hence there are major confounders 
affecting the relationship between infection prevalence 
and ITN use. Very often ITN use is greatest amongst 
people with highest risk. For example, according to the 
2014 World Malaria Report [2] pregnant women and 
children were more likely than the general population 
to sleep under an ITN since net distribution campaigns 
often target these groups. This in turn may lead to appar-
ently higher malaria prevalence overall amongst ITN 
users than non-users. As a result it will appear as if ITNs 
are ineffective. An additional problem with this approach 
is that reported net use (whether accurate or not) is often 
very high in cohorts where the standard question of 
net-use last night is asked at every visit. As a result, the 
non-user comparison group is very small and probably 
unrepresentative, leading to a biased estimate.
Despite these challenges, this study will generate 
approximately 300 observations of malaria incidence in 
communities protected by LLINs (in some instances in 
combination with IRS), and concomitant IR across mul-
tiple time points and transmission settings. If IR has a 
profound impact on the effectiveness of these interven-
tions, an association between these two measures should 
be evident. The advantage of the chosen design is that the 
formation of many study clusters results in a relatively 
large sample of independent paired observations of IR 
and malaria incidence. The harmonization of methods 
across countries will provide the possibility of combining 
data across countries for analysis.
The historical data from South Africa [10] suggest 
as much as a ten-fold increase in malaria incidence if 
there is resistance to the IRS insecticide. On the other 
hand, studies comparing the effectiveness of ITNs and 
untreated nets [39] showed that untreated nets are 
approximately half as effective as treated nets in settings 
of insecticide susceptibility, suggesting a potential two-
fold increase in malaria burden resulting from resistance 
to insecticides used on ITNs, other factors remaining 
the same. This study will be able provide some evidence 
based insights into this question.
Conclusion
The multi-country study described in this paper, despite 
many inherent challenges associated with study design 
and measurement of resistance, is unique in assembling 
a large data set of connected entomological and epi-
demiological observations. It will provide quantitative 
insights on the impact that IR has on the effectiveness 
of malaria vector control, and the potential for control 
programme failure. The findings will be important for 
determining the urgency with which management of 
IR should be undertaken, and the effort and investment 
that are required in the search for alternatives to current 
insecticide-based tools for the control and elimination of 
malaria.
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